Evidence map›Paper›PMID 39733398›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2024

Serum and Salivary Levels of Phosphate in Gastric and Colorectal Cancer Patients.

Mohammad Hossein Hajali, Hamidreza Karbalaei-Musa, Mohammad Arbaghaei, Mohsen Rajaeinejad, Peyman Aslani, Iraj Mirzaii-Dizgah

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mohammad Hossein HajaliStudent Research Committee, AJA University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-5775-2049
Hamidreza Karbalaei-MusaStudent Research Committee, AJA University of Medical Sciences, Tehran, Iran.ORCID 0009-0002-5899-3319
Mohammad ArbaghaeiStudent Research Committee, AJA University of Medical Sciences, Tehran, Iran.ORCID 0009-0007-3865-6928
Mohsen RajaeinejadAJA Cancer Epidemiology Research and Treatment Center (AJA-CERTC), AJA University of Medical Sciences, Tehran, Iran.
Peyman AslaniDepartment of Medical Mycology, School of Medicine, Aja University of Medical Sciences, Tehran, Iran.
Iraj Mirzaii-DizgahDepartment of Physiology, School of Medicine, Aja University of Medical Sciences, Tehran, Iran.ORCID 0000-0003-3488-6842

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveGastrointestinal cancer is one of the most common causes of death worldwide. As there are no clinical symptoms at the beginning of the disease, the diagnosis can be delayed and the stage increased. Timely diagnosis is therefore crucial. Since one of the factors involved in cell division is phosphate, and considering the benefits of using saliva, this study investigated the phosphate concentration in saliva and serum in patients with gastric and colorectal cancer as well as in healthy patients.

methods26 patients with gastric and colorectal cancer confirmed by pathologic criteria were admitted to the oncology department of Imam Reza Hospital, and 30 healthy individuals participated in this study. Saliva and serum samples were collected in the morning. Phosphate concentration was determined using a photometric method.

resultsThe average phosphate content in serum as well as in stimulated and unstimulated saliva was significantly lower in the patient group. In addition, the results showed that the patients reported more dry mouth than the control group despite increased salivary flow.

conclusionIt appears that patients with malignant diseases of the gastrointestinal tract, such as colorectal cancer and gastric cancer, have lower serum and salivary phosphate levels than healthy individuals.

Indexed as

Colorectal NeoplasmsPhosphatesSalivaStomach NeoplasmsAdultAgedBiomarkers, TumorCase-Control StudiesFemaleFollow-Up StudiesHumansMaleMiddle AgedPrognosisBiomarkers, TumorPhosphatescolorectal cancerGastric cancerphosphateSalivaSerum

Identifiers

PMID39733398
PMCPMC12008317

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.